Article
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
23 Apr 2024
Abstract excerpt
Despite advancements in utilizing genetic markers to enhance acute myeloid leukaemia (AML) outcome prediction, significant disease heterogeneity persists, hindering clinical management. To refine survival predictions, we assessed the transcriptome of non-acute promyelocytic leukaemia chemotherapy-treated AML patients from five cohorts (n = 975). This led to the identification of a 4-gene prognostic index (4-PI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
